GSK's Jemperli meets main goal in mid-stage rectal cancer trial
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A mid-stage trial for GSK's Jemperli has reportedly met its main goal in treating rectal cancer. The trial's outcome suggests Jemperli may be effective for this type of cancer. Further details of the trial's results are not specified.